An exploratory in silico analysis of bacteriocin gene clusters in the urobiome

Abstract

Background: The role of the urobiome in health and disease remains an understudied area compared to the rest of the human microbiome. Enhanced culturing techniques and next-generation sequencing technologies have identified the urobiome as an untapped source of potentially novel antimicrobials. The aim of this study was to screen the urobiome for genes encoding bacteriocin production.

Methods: The genomes of 181 bacterial urobiome isolates were screened in silico for the presence of bacteriocin gene clusters using the bacteriocin mining tool BAGEL4 and secondary metabolite screening tool antiSMASH7.

Results: From these isolates, an initial 263 areas of interest were identified, manually annotated, and evaluated for potential bacteriocin gene clusters. This resulted in 32 isolates containing 80 potential bacteriocin gene clusters, of which 72% were identified as class II, 13.75% as class III, 8.75% as class I, and 5% as unclassified bacteriocins.

Conclusion: Overall, 53 novel variants were discovered, including nisin, gassericin, ubericin, and colicins.

Keywords

Urobiome / bacteriocins / antibiotic resistance / BAGEL4 / bacteriocin gene cluster

References

[1] Aragón IM,Queipo-Ortuño MI.The urinary tract microbiome in health and disease.Eur Urol Focus2018;4:128-38

[2] Newstead LL,Nuttall T.Staphylococcal-produced bacteriocins and antimicrobial peptides: their potential as alternative treatments for Staphylococcus aureus infections.Antibiotics2020;9:40 PMCID:PMC7168290

[3] Valles-Colomer M,Cumbo F.Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding.EBioMedicine2024;99:104917 PMCID:PMC10731604

[4] Xie J,Deng X.Gut microbiota reshapes cancer immunotherapy efficacy: mechanisms and therapeutic strategies.iMeta2024;3:e156

[5] Zheng J,Lin XB,Sun M.Diversity and dynamics of bacteriocins from human microbiome.Environ Microbiol2015;17:2133-43

[6] Mousa WK,Merwin NJ.Antibiotics and specialized metabolites from the human microbiota.Nat Prod Rep2017;34:1302-31

[7] Culligan EP.Advances in the microbiome: applications to Clostridium difficile infection.J Clin Med2016;5:83 PMCID:PMC5039486

[8] O’Sullivan JN,O’Connor PM,Ross RP.Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens.FEMS Microbiol Ecol2019;95:fiy241 PMCID:PMC6340406

[9] Wosinska L,O’Connor PM.In vitro and in silico based approaches to identify potential novel bacteriocins from the athlete gut microbiome of an elite athlete cohort.Microorganisms2022;10:701 PMCID:PMC9025905

[10] Angelopoulou A,O’Connor PM.Diverse bacteriocins produced by strains from the human milk microbiota.Front Microbiol2020;11:788 PMCID:PMC7248182

[11] King AM,Glassey E,Clardy J.Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra.Nat Microbiol2023;8:2420-34

[12] Jones J,Sleator RD.The urobiome, urinary tract infections, and the need for alternative therapeutics.Microb Pathog2021;161:105295

[13] Brubaker L,Dong Q.The human urobiome.Mamm Genome2021;32:232-8

[14] Acedo JZ,Vederas JC.The expanding structural variety among bacteriocins from Gram-positive bacteria.FEMS Microbiol Rev2018;42:805-28

[15] Chikindas ML,Drider D,Dicks LM.Functions and emerging applications of bacteriocins.Curr Opin Biotechnol2018;49:23-8 PMCID:PMC5799035

[16] Riley MA.Bacteriocins: evolution, ecology, and application.Annu Rev Microbiol2002;56:117-37

[17] Héchard Y.Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.Biochimie2002;84:545-57

[18] Heilbronner S,Brötz-Oesterhelt H.The microbiome-shaping roles of bacteriocins.Nat Rev Microbiol2021;19:726-39

[19] Chavan MA.Molecular evolution of bacteriocins in gram-negative bacteria. In: Riley MA, Chavan MA, editors. Bacteriocins. Berlin: Springer Berlin Heidelberg; 2007. pp. 19-43.

[20] Ghodhbane H,Sabatier JM,Benhmida J.Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections.Infect Disord Drug Targets2015;15:2-12

[21] Jack RW,Ray B.Bacteriocins of gram-positive bacteria.Microbiol Rev1995;59:171-200 PMCID:PMC239359

[22] Klaenhammer TR.Bacteriocins of lactic acid bacteria.Biochimie1988;70:337-49

[23] Cotter PD,Hill C.Bacteriocins - a viable alternative to antibiotics?.Nat Rev Microbiol2013;11:95-105

[24] Benítez-Chao DF,Lerma-Escalera JA.Bacteriocins: an overview of antimicrobial, toxicity, and biosafety assessment by in vivo models.Front Microbiol2021;12:630695 PMCID:PMC8083986

[25] Egan K,Ross RP,Hill C.In silico prediction and exploration of potential bacteriocin gene clusters within the bacterial genus Geobacillus.Front Microbiol2018;9:2116 PMCID:PMC6160750

[26] van Heel AJ, de Jong A, Song C, Viel JH, Kok J, Kuipers OP. BAGEL4: a user-friendly web server to thoroughly mine RiPPs and bacteriocins.Nucleic Acids Res2018;46:W278-81 PMCID:PMC6030817

[27] Blin K,Augustijn HE.antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation.Nucleic Acids Res2023;51:W46-50 PMCID:PMC10320115

[28] Collins FWJ,O’Sullivan O.Bacteriocin gene-trait matching across the complete Lactobacillus pan-genome.Sci Rep2017;7:3481 PMCID:PMC5471241

[29] Conrads G,Lürkens M.Isolation and bacteriocin-related typing of Streptococcus dentisani.Front Cell Infect Microbiol2019;9:110 PMCID:PMC6476965

[30] Miller-Ensminger T,Brenner J.Bacteriophages of the urinary microbiome.J Bacteriol2018;200:e00738-17 PMCID:PMC5847656

[31] Altschul SF,Miller W,Lipman DJ.Basic local alignment search tool.J Mol Biol1990;215:403-10

[32] Brubaker L,Siddiqui NY.Forming consensus to advance urobiome research.mSystems2021;6:e0137120 PMCID:PMC8409733

[33] Walsh CJ,Hill C,O’Toole PW.In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database.BMC Microbiol2015;15:183 PMCID:PMC4573289

[34] Christenson JK.Evolution of colicin BM plasmids: the loss of the colicin B activity gene.Microbiology2009;155:1645-55

[35] Wolfe AJ.Urobiome updates: advances in urinary microbiome research.Nat Rev Urol2019;16:73-4 PMCID:PMC6628711

[36] Roth RS,Huttner A.The urobiome in men and women: a clinical review.Clin Microbiol Infect2023;29:1242-8

[37] Daba GM.Bacteriocins of lactic acid bacteria as biotechnological tools in food and pharmaceuticals: current applications and future prospects.Biocatal Agric Biotechnol2020;28:101750

[38] Mokoena MP.Lactic acid bacteria and their bacteriocins: classification, biosynthesis and applications against uropathogens: a mini-review.Molecules2017;22:1255 PMCID:PMC6152299

[39] Dawid S,Weiser JN.The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo.Infect Immun2007;75:443-51 PMCID:PMC1828380

[40] Franz CMAP,Holzapfel WH,Gálvez A.Diversity of enterococcal bacteriocins and their grouping in a new classification scheme.FEMS Microbiol Rev2007;31:293-310

[41] Kasuga G,Harada Y.Homologous expression and characterization of gassericin T and gassericin S, a novel class IIb bacteriocin produced by Lactobacillus gasseri LA327.Appl Environ Microbiol2019;85:e02815-18 PMCID:PMC6414389

[42] Vassiliadis G,Lombard C,Peduzzi J.Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47.Antimicrob Agents Chemother2010;54:288-97 PMCID:PMC2798501

[43] Garcia-Gutierrez E,Colquhoun IJ.Production of multiple bacteriocins, including the novel bacteriocin gassericin M, by Lactobacillus gasseri LM19, a strain isolated from human milk.Appl Microbiol Biotechnol2020;104:3869-84 PMCID:PMC7162838

[44] Jiang H,Gu Q.Heterologous expression and purification of plantaricin NC8, a two-peptide bacteriocin against Salmonella spp. from Lactobacillus plantarum ZJ316.Protein Expr Purif2016;127:28-34

[45] Jamalifar H,Samadi N.Antimicrobial activity of different Lactobacillus species against multi-drug resistant clinical isolates of Pseudomonas aeruginosa.Iran J Microbiol2011;3:21-5 PMCID:PMC3279796

[46] Butler DSC,Stapleton AE.Cytoprotective effect of Lactobacillus crispatus CTV-05 against Uropathogenic E. coli.Pathogens2016;5:27 PMCID:PMC4810148

[47] Reid G,Fraser N,Owen J.Oral probiotics can resolve urogenital infections.FEMS Immunol Med Microbiol2001;30:49-52

[48] Ya W,Miller LE.Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study.Am J Obstet Gynecol2010;203:120.e1-6

[49] Beyitler I.Probiotics for prophylaxis and treatment of urinary tract infections in children.Iran J Pediatr2016;27:e7695

[50] Hilt EE,Pearce MM.Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder.J Clin Microbiol2014;52:871-6 PMCID:PMC3957746

[51] Tagg JR,Wannamaker LW.Bacteriocins of gram-positive bacteria.Bacteriol Rev1976;40:722-56 PMCID:PMC413978

[52] Nes IF,Holo H.Bacteriocin diversity in Streptococcus and Enterococcus.J Bacteriol2007;189:1189-98 PMCID:PMC1797368

[53] De Vuyst L, Tsakalidou E. Streptococcus macedonicus, a multi-functional and promising species for dairy fermentations.Int Dairy J2008;18:476-85

[54] Lasagno M,Moliva M.Screening of bacteriocin associated genes of Streptococcus uberis strains.Heliyon2019;5:e02393 PMCID:PMC6744602

[55] Christ K,Wiedemann I,Sahl HG.Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.J Membr Biol2008;226:9-16

[56] Wirawan RE,Jack RW.Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis.Appl Environ Microbiol2006;72:1148-56 PMCID:PMC1392965

[57] Marković KG,Koraćević MG.Colicins and microcins produced by Enterobacteriaceae: characterization, mode of action, and putative applications.Int J Environ Res Public Health2022;19:11825 PMCID:PMC9517006

[58] Hahn-Löbmann S,Schulz S.Colicins and salmocins - new classes of plant-made non-antibiotic food antibacterials.Front Plant Sci2019;10:437 PMCID:PMC6465592

[59] Hussein AR,Kadhim MJ.The antibiofilm activity of bacteriocin produced by Proteus mirabilis against some bacterial species.Curr Res Microbiol Biotechnol2017;5:1071-7Available from: https://www.researchgate.net/profile/Alyaa-Hussein-2/publication/328052134_The_antibiofilm_activity_of_bacteriocin_produced_by_Proteus_mirabilis_against_some_bacterial_species/links/5bb5208ca6fdccd3cb8517fd/The-antibiofilm-activity-of-bacteriocin-produced-by-Proteus-mirabilis-against-some-bacterial-species.pdf. [Last accessed on 26 Mar 2024]

[60] Roy SM.Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia coli.Int J Antimicrob Agents2019;54:619-25

[61] Sharp C,Cain A.O-antigen-dependent colicin insensitivity of uropathogenic Escherichia coli.J Bacteriol2019;201:e00545-18 PMCID:PMC6351738

[62] Sharma D,Seshadri S.Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications.Microbiome Res Rep2024;3:3 PMCID:PMC10917622

[63] Sassone-Corsi M,Liu H.Microcins mediate competition among Enterobacteriaceae in the inflamed gut.Nature2016;540:280-3 PMCID:PMC5145735

[64] Culligan EP,Sleator RD.Probiotics and gastrointestinal disease: successes, problems and future prospects.Gut Pathog2009;1:19 PMCID:PMC2789095

[65] Ellis JC,Hill C.Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria.Future Microbiol2019;14:1573-87